Embecta EMBC
NASDAQ EMBC
$5.61 +0.02 (+0.36%)
As of: Sep 23, 2026 · 10:05 AM EDT

Embecta (EMBC) Non Operating Income (2021 - 2026)

Embecta's (EMBC) quarterly Non Operating Income came in at $2.8 million in Q2 2026, down 41.67% year-over-year from $4.8 million in Q2 2025, and up 196.55% quarter-over-quarter from -$2.9 million in Q1 2026.

Analysis

Embecta (EMBC) Non Operating Income (2021 - 2026) Analysis & Trends

Embecta has disclosed Non Operating Income across 6 years of filings, most recently posting $2.8 million for Q2 2026.

  • In Q2 2026, Non Operating Income fell 41.67% year-over-year to $2.8 million; the TTM figure through Jun 2026 stood at -$1.8 million (down 38.46% YoY), while the FY2025 annual figure was $1.5 million, up 114.56% from the prior year.
  • Non Operating Income came in at $2.8 million for Q2 2026 at Embecta, up from -$2.9 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.8 million in Q3 2023 to a low of -$7.1 million in Q4 2022.
  • Average Non Operating Income over 5 years is -$1.4 million, with a median of -$1.5 million recorded in 2024.
  • Year-over-year, Non Operating Income slumped 4200.0% in 2023 and jumped 536.36% in 2025.
  • Over 5 years, Non Operating Income stood at -$7.1 million in 2022, then surged by 50.7% to -$3.5 million in 2023, then surged by 57.14% to -$1.5 million in 2024, then jumped by 80.0% to -$300000.0 in 2025, then soared by 1033.33% to $2.8 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were $2.8 million in Q2 2026, -$2.9 million in Q1 2026, and -$300000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Thermo Fisher Scientific 243.61 Bn 239.66 Bn 8.34 Bn -
2 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn -
3 Danaher 155.49 Bn 151.15 Bn 3.61 Bn -
4 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 82.70 Mn
5 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn -
6 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 46.00 Mn
7 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn -
8 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn 6.60 Mn
9 Becton Dickinson 49.86 Bn 48.99 Bn 2.32 Bn -
10 Embecta 316.73 Mn 98.53 Mn 153.30 Mn 2.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.80 Mn
Mar 31, 2026 -2.90 Mn
Dec 31, 2025 -300,000.00
Sep 30, 2025 -1.40 Mn
Jun 30, 2025 4.80 Mn
Mar 31, 2025 -400,000.00
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 -4.20 Mn
Jun 30, 2024 -1.10 Mn
Mar 31, 2024 -1.50 Mn
Dec 31, 2023 -3.50 Mn
Sep 30, 2023 6.80 Mn
Jun 30, 2023 -4.20 Mn
Mar 31, 2023 -4.30 Mn
Dec 31, 2022 -7.10 Mn
Sep 30, 2022 -2.70 Mn
Jun 30, 2022 -4.00 Mn
Mar 31, 2022 -100,000.00
Sep 30, 2021 -800,000.00
Jun 30, 2021 600,000.00
API Access

Embecta Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=EMBC&period=max&api_key=YOUR_API_KEY